Alhomieed Maya Faissal, Al Hartany Lara Osama, Alghorab Marya Aref, Alsharif Arwa, Kaleemullah Ahlam, Wasaya Hanan Ismail, Alsubaie Khlood Abdulaziz, Al Jehani Ayah Nabil, Kayali Amal Mohamed, AlBasri Samera
Department of Medicine and Surgery, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
Obsetetrics and Gynecology Department, King Abdulaziz University Hospital, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Clin Pract. 2025 Mar 21;15(4):68. doi: 10.3390/clinpract15040068.
: Pregnancy induces hormonal, immunologic, and vascular changes that profoundly affect dermatologic health. This systematic review aimed to assess the impact of pregnancy on dermatological disorders in terms of disease incidence, severity, maternal-fetal outcomes, and optimal management strategies. : A systematic search was performed in PubMed, MEDLINE, and Web of Science databases, following PRISMA guidelines. Studies evaluating pregnant women with dermatological disorders, pregnancy-related dermatoses, and pre-existing morbidities, were included. The collaboratively extracted data included patient demographics, disease severity, treatment approaches, and pregnancy outcomes. : A total of 8490 pregnant cases with dermatologic changes and conditions caused by pregnancy were studied. The dermatological conditions were divided into physiological changes, pregnancy-related exacerbation of pre-existing skin conditions, and pregnancy-specific dermatoses. Intrahepatic cholestasis of pregnancy and pemphigoid gestationis were associated with increased rates of adverse fetal outcomes in patients with specific dermatoses, including increased preterm birth and fetal distress rates. The atopic eruption of pregnancy and polymorphic eruption of pregnancy were highly relevant, but their effect on fetal health was minimal. The efficacy and safety of treatment modalities, including corticosteroids, antihistamines, and ursodeoxycholic acid, were variable. : Pregnancy drastically affects dermatological health, but the nature of the impact depends on the condition. Optimal maternal and fetal outcomes rely on early diagnosis and individualized management strategies. More randomized controlled trials are required to develop standardized diagnostic and treatment guidelines to enhance the quality of dermatologic care during pregnancy.
妊娠会引发激素、免疫和血管变化,这些变化会深刻影响皮肤健康。本系统评价旨在从疾病发病率、严重程度、母婴结局和最佳管理策略等方面评估妊娠对皮肤病的影响。
按照PRISMA指南,在PubMed、MEDLINE和科学网数据库中进行了系统检索。纳入了评估患有皮肤病、妊娠相关皮肤病和既往疾病的孕妇的研究。共同提取的数据包括患者人口统计学信息、疾病严重程度、治疗方法和妊娠结局。
共研究了8490例因妊娠引起皮肤变化和状况的妊娠病例。皮肤病状况分为生理变化、既往皮肤疾病的妊娠相关加重以及妊娠特异性皮肤病。妊娠肝内胆汁淤积症和妊娠类天疱疮与特定皮肤病患者不良胎儿结局的发生率增加有关,包括早产率和胎儿窘迫率增加。妊娠性特应性皮疹和妊娠多形性皮疹高度相关,但其对胎儿健康的影响最小。包括皮质类固醇、抗组胺药和熊去氧胆酸在内的治疗方式的疗效和安全性各不相同。
妊娠会极大地影响皮肤健康,但影响的性质取决于具体情况。最佳的母婴结局依赖于早期诊断和个体化管理策略。需要更多的随机对照试验来制定标准化的诊断和治疗指南,以提高孕期皮肤病护理的质量。